Showing results (461-470 of 977) with videos related to

Sort By:
Pageof 98
NPJ Breast Cancer|March 18, 2026
Peri-lymphatic cytokines (IRX-2) as immunologic induction preceding neoadjuvant chemo-immunotherapy in triple-negative breast cancerAlan Su, Erin C Hong, Nicole Moxon, et al.
NPJ Breast Cancer|March 28, 2026
Disparities in breast cancer incidence and survival by age, race, and molecular subtype in US womenLin Wang, Zhihao Wan, Vikramjit Dhillon, et al.
NPJ Breast Cancer|March 19, 2026
Comprehensive genomic analysis of non-BRCA familial breast cancer in an Arab populationEhsan Ullah, Hikmat Abdel-Razeq, Sana Bentebbal, et al.
NPJ Breast Cancer|April 4, 2026
Investigating the contribution of rare non-coding variants in BRCA1, BRCA2 and PALB2 to hereditary breast cancerQihong Zhao, Na Li, Evanny Marinovic, et al.
NPJ Breast Cancer|March 21, 2026
A multi-ancestry genome-wide study of tamoxifen metabolism and breast cancer recurrenceChiea Chuen Khor, Whee Sze Ong, Elaine Hsuen Lim, et al.
NPJ Breast Cancer|March 20, 2026
Identification of racial disparities across MammaPrint and BluePrint subtypes in HR + HER2- breast cancerSonya Reid, Lindsay Venton, Jennifer G Whisenant, et al.
NPJ Breast Cancer|May 9, 2026
Risk factors and metastatic sites in HER2-positive breast cancer with pathological complete responseMayako Terao, Hiraku Kumamaru, Naoko Kinukawa, et al.
NPJ Breast Cancer|April 16, 2026
Acute circulating tumor DNA dynamics during and after systemic therapy initiation for advanced triple-negative breast cancerBriana To, Vishnu Prasath, Deloris Veney, et al.
NPJ Breast Cancer|May 14, 2026
AI-powered and manual assessment of tumor-infiltrating lymphocytes in early HER2-positive breast cancer in NSABP B-41Ilana Schlam, Gong Tang, Khalid AbdulJabbar, et al.
NPJ Breast Cancer|June 2, 2026
Diagnostic Performance of 68Ga-FAPI PET/CT Versus 18F-FDG PET/CT in Evaluating Neoadjuvant Therapy Pathological Response in Breast CancerSiji Zhu, Yihua Jin, Chao Hu, et al.
Pageof 98